These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1490193)

  • 21. Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
    Monlux WS; Luedke AJ; Mercado S; Rosales JC
    J Am Vet Med Assoc; 1972 Oct; 161(7):832-3. PubMed ID: 5074265
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.
    Olinger GG; Bailey MA; Dye JM; Bakken R; Kuehne A; Kondig J; Wilson J; Hogan RJ; Hart MK
    J Virol; 2005 Nov; 79(22):14189-96. PubMed ID: 16254354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of arbovirus attenuation by changes in the histamine level in the blood of immunized animals].
    Beketova ZP; Vasil'eva OA
    Vopr Virusol; 1975; (2):151-5. PubMed ID: 1241175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
    Jochim MM; Barber TL; Luedke AJ
    J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys.
    Jahrling PB; Hilmas DE; Heard CD
    Arch Virol; 1977; 55(1-2):161-4. PubMed ID: 411457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venezuelan equine encephalitis.
    Weaver SC; Ferro C; Barrera R; Boshell J; Navarro JC
    Annu Rev Entomol; 2004; 49():141-74. PubMed ID: 14651460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.
    Williams AJ; O'Brien LM; Phillpotts RJ; Perkins SD
    Virol J; 2009 Jul; 6():118. PubMed ID: 19646224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An attenuated mutant of Venezuelan encephalitis virus: biochemical alterations and their genetic association with attenuation.
    Emini EA; Wiebe ME
    Virology; 1981 Apr; 110(1):185-96. PubMed ID: 7210503
    [No Abstract]   [Full Text] [Related]  

  • 33. Venezuelan equine encephalomyelitis viral infection of newly hatched chickens and embryonating eggs.
    Dickerman RW; Bonacorsa CM
    Am J Vet Res; 1975 Aug; 36(08):1231-3. PubMed ID: 1155839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic VEE subtype I-E or II viruses.
    Sneider JM; Kinney RM; Tsuchiya KR; Trent DW
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():519-23. PubMed ID: 8445371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Variants of the Venezuelan equine encephalomyelitis virus resistant to the neutralizing action of monoclonal antibodies].
    Agapov EV; Lebedeva SD; Razumov IA; Frolov IV; Kolykhalov AA; Loktev VB; Netesov SV; Sandakhchiev LS
    Dokl Akad Nauk SSSR; 1991; 320(6):1485-8. PubMed ID: 1804615
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
    Elvin SJ; Bennett AM; Phillpotts RJ
    J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of fragments of Venezuelan equine encephalomyelitis virus E2 protein in a system based on phage T7 RNA polymerase].
    Il'ichev AA; Melamed NV; Razumov IA; Maksiutov AZ; Pereboev AV; Zakabunin AI; Loktev VB
    Mol Biol (Mosk); 1996; 30(1):76-83. PubMed ID: 8714124
    [No Abstract]   [Full Text] [Related]  

  • 40. Venezuelan equine encephalomyelitis virus (VEEV):strain differentiation and specification of virulence markers.
    Walder R; Bradish CJ
    J Gen Virol; 1975 Mar; 26(3):265-75. PubMed ID: 804536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.